comprehensive -WSS

comprehensive

author：leisure time 2025-09-28 00:50:51 - browse：1953

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： CDC launches VaccineFinder tool to locate Covid

WSS

Sage's campaign to raise awareness of postpartum depression hits a nerve

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Medicare says breakthrough device reimbursement rule to come by summer

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Study: AI not yet building 'n

focus

comprehensive

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

Dairy farmers resist CDC push for PPE against bird flu virus

United colonoscopy coverage change 'may cost lives,' doctors say

Brain worms: The science behind RFK Jr.'s parasitic infection

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Choosing scientific sides in the fight against Alzheimer's

Hepatitis C has a cure — but many Americans still lack access to it

Readout LOUD podcast: What to know about H5N1 bird flu

How to save PrEP access — and even expand it

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

focus

CDC wastewater surveillance dashboard to track bird flu hotspots

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Germany receives 178 compensation applications from gay servicepeople over discrimination

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

The painfully weak evidence on taking collagen to treat arthritis

Use wet bulb globe temperature, not heat index, to protect workers

leisure time

focus

explore

Wikipedia